Abstract
IntroductionSirolimus is a mammalian target of rapamycin (mTOR) inhibitor and well-known for its anti-tumour effect increasing the tumour disappearance rate of rhabdomyoma. Cardiac rhabdomyomas are a rare condition associated with...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
